Platelet activating factor antagonists
US5459152A · kind A · utility
6Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 1993 |
| Grant date | Oct 17, 1995 |
| Priority date | — |
| Expiry date | Dec 2, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Indole compounds substituted at the 3-position by a 7-carbonyl(pyridin-3-yl)pyrrolo[1,2-c]thiazole, 7-carbonyl(pyridin-3-yl)pyrrolo[1,2-c]oxazole, or 7-carbonyl(pyridin-3-yl)pyrrolo[1,2-c]pyrrole group are potent antagionists of PAF and are useful in the treatment of PAF-related disorders including asthma, shock, respiratory distress syndrome, acute inflammation, transplanted organ rejection, gastrointesinal ulceration, allergic skin diseases, delayed cellular immunity, parturition, fetal lung maturation, and cellular differentiation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.